• Je něco špatně v tomto záznamu ?

Patient satisfaction with ultrasound, whole-body CT and whole-body diffusion-weighted MRI for pre-operative ovarian cancer staging: a multicenter prospective cross-sectional survey

P. Pinto, L. Valentin, M. Borčinová, M. Wiesnerová, F. Filip, A. Burgetova, M. Masek, L. Lambert, V. Chiappa, D. Franchi, AC. Testa, F. Moro, G. Avesani, C. Panico, S. Alessi, P. Pricolo, R. Vigorito, G. Calareso, R. Kocian, J. Slama, A. Fagotti,...

. 2024 ; 34 (6) : 871-878. [pub] 20240603

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013586
E-zdroje Online Plný text

NLK ProQuest Central od 2001-01-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 2001-01-01 do Před 6 měsíci

BACKGROUND: In addition to the diagnostic accuracy of imaging methods, patient-reported satisfaction with imaging methods is important. OBJECTIVE: To report a secondary outcome of the prospective international multicenter Imaging Study in Advanced ovArian Cancer (ISAAC Study), detailing patients' experience with abdomino-pelvic ultrasound, whole-body contrast-enhanced computed tomography (CT), and whole-body diffusion-weighted magnetic resonance imaging (WB-DWI/MRI) for pre-operative ovarian cancer work-up. METHODS: In total, 144 patients with suspected ovarian cancer at four institutions in two countries (Italy, Czech Republic) underwent ultrasound, CT, and WB-DWI/MRI for pre-operative work-up between January 2020 and November 2022. After having undergone all three examinations, the patients filled in a questionnaire evaluating their overall experience and experience in five domains: preparation before the examination, duration of examination, noise during the procedure, radiation load of CT, and surrounding space. Pain perception, examination-related patient-perceived unexpected, unpleasant, or dangerous events ('adverse events'), and preferred method were also noted. RESULTS: Ultrasound was the preferred method by 49% (70/144) of responders, followed by CT (38%, 55/144), and WB-DWI/MRI (13%, 19/144) (p<0.001). The poorest experience in all domains was reported for WB-DWI/MRI, which was also associated with the largest number of patients who reported adverse events (eg, dyspnea). Patients reported higher levels of pain during the ultrasound examination than during CT and WB-DWI/MRI (p<0.001): 78% (112/144) reported no pain or mild pain, 19% (27/144) moderate pain, and 3% (5/144) reported severe pain (pain score >7 of 10) during the ultrasound examination. We did not identify any factors related to patients' preferred method. CONCLUSION: Ultrasound was the imaging method preferred by most patients despite being associated with more pain during the examination in comparison with CT and WB-DWI/MRI. TRIAL REGISTRATION NUMBER: NCT03808792.

1st Faculty of Medicine Charles University Prague Czech Republic

Department of Clinical Sciences Malmö Lund University Lund Sweden

Department of Gynecologic Oncology Foundation IRCCS National Cancer Institute Milan Italy

Department of Gynecology Portuguese Institute of Oncology of Lisbon Francisco Gentil Lisboa Portugal

Department of Obstetrics and Gynaecology Skane University Hospital Malmo Sweden

Department of Radiology 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Department of Radiology Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

Dipartimento di Diagnostica per Immagini Radioterapia Oncologica ed Ematologia Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Lazio Italy

Dipartimento Scienze della Salute della Donna del Bambino e di Sanità Pubblica Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Lazio Italy

Dipartimento Scienze della Vita e Sanità Pubblica Università Cattolica del Sacro Cuore Rome Italy

Division of Radiology Istituto Europeo di Oncologia Milan Italy

Gynecologic Oncology Centre Department of Gynecology Obstetrics and Neonatology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Masaryk University Institute of Biostatistics and Analyses Brno Czech Republic

Preventive Gynecology Unit Division of Gynaecology European Institute of Oncology Milan Italy

Preventive Gynecology Unit Division of Gynecology European Institute of Oncology Milan Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013586
003      
CZ-PrNML
005      
20240905134016.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/ijgc-2023-005264 $2 doi
035    __
$a (PubMed)38531539
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Pinto, Patrícia $u Department of Gynecology, Portuguese Institute of Oncology of Lisbon Francisco Gentil, Lisboa, Portugal $u First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000264598529
245    10
$a Patient satisfaction with ultrasound, whole-body CT and whole-body diffusion-weighted MRI for pre-operative ovarian cancer staging: a multicenter prospective cross-sectional survey / $c P. Pinto, L. Valentin, M. Borčinová, M. Wiesnerová, F. Filip, A. Burgetova, M. Masek, L. Lambert, V. Chiappa, D. Franchi, AC. Testa, F. Moro, G. Avesani, C. Panico, S. Alessi, P. Pricolo, R. Vigorito, G. Calareso, R. Kocian, J. Slama, A. Fagotti, AMV. Urbinati, M. Signorelli, F. Bertolina, D. Cibula, D. Fischerova
520    9_
$a BACKGROUND: In addition to the diagnostic accuracy of imaging methods, patient-reported satisfaction with imaging methods is important. OBJECTIVE: To report a secondary outcome of the prospective international multicenter Imaging Study in Advanced ovArian Cancer (ISAAC Study), detailing patients' experience with abdomino-pelvic ultrasound, whole-body contrast-enhanced computed tomography (CT), and whole-body diffusion-weighted magnetic resonance imaging (WB-DWI/MRI) for pre-operative ovarian cancer work-up. METHODS: In total, 144 patients with suspected ovarian cancer at four institutions in two countries (Italy, Czech Republic) underwent ultrasound, CT, and WB-DWI/MRI for pre-operative work-up between January 2020 and November 2022. After having undergone all three examinations, the patients filled in a questionnaire evaluating their overall experience and experience in five domains: preparation before the examination, duration of examination, noise during the procedure, radiation load of CT, and surrounding space. Pain perception, examination-related patient-perceived unexpected, unpleasant, or dangerous events ('adverse events'), and preferred method were also noted. RESULTS: Ultrasound was the preferred method by 49% (70/144) of responders, followed by CT (38%, 55/144), and WB-DWI/MRI (13%, 19/144) (p<0.001). The poorest experience in all domains was reported for WB-DWI/MRI, which was also associated with the largest number of patients who reported adverse events (eg, dyspnea). Patients reported higher levels of pain during the ultrasound examination than during CT and WB-DWI/MRI (p<0.001): 78% (112/144) reported no pain or mild pain, 19% (27/144) moderate pain, and 3% (5/144) reported severe pain (pain score >7 of 10) during the ultrasound examination. We did not identify any factors related to patients' preferred method. CONCLUSION: Ultrasound was the imaging method preferred by most patients despite being associated with more pain during the examination in comparison with CT and WB-DWI/MRI. TRIAL REGISTRATION NUMBER: NCT03808792.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    12
$a nádory vaječníků $x diagnostické zobrazování $x patologie $7 D010051
650    _2
$a prospektivní studie $7 D011446
650    _2
$a lidé středního věku $7 D008875
650    12
$a difuzní magnetická rezonance $x metody $7 D038524
650    _2
$a průřezové studie $7 D003430
650    12
$a ultrasonografie $x metody $7 D014463
650    _2
$a senioři $7 D000368
650    12
$a počítačová rentgenová tomografie $x metody $7 D014057
650    12
$a spokojenost pacientů $7 D017060
650    _2
$a dospělí $7 D000328
650    _2
$a staging nádorů $7 D009367
650    _2
$a celotělové zobrazování $x metody $7 D051598
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a předoperační péče $x metody $7 D011300
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Valentin, Lil $u Department of Obstetrics and Gynaecology, Skane University Hospital, Malmo, Sweden $u Department of Clinical Sciences Malmö, Lund University, Lund, Sweden
700    1_
$a Borčinová, Martina $u Gynecologic Oncology Centre, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/000000025016149X
700    1_
$a Wiesnerová, Markéta $u Masaryk University Institute of Biostatistics and Analyses, Brno, Czech Republic
700    1_
$a Filip, Fruhauf $u Gynecologic Oncology Centre, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Burgetova, Andrea $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Masek, Martin $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Lambert, Lukas $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Chiappa, Valentina $u Department of Gynecologic Oncology, Foundation IRCCS National Cancer Institute, Milan, Italy
700    1_
$a Franchi, Dorella $u Preventive Gynecology Unit, Division of Gynaecology, European Institute of Oncology, Milan, Italy
700    1_
$a Testa, Antonia Carla $u Dipartimento Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy $u Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Lazio, Italy
700    1_
$a Moro, Francesca $u Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Lazio, Italy $1 https://orcid.org/0000000250707245
700    1_
$a Avesani, Giacomo $u Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Lazio, Italy $1 https://orcid.org/000000019926760X
700    1_
$a Panico, Camilla $u Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Lazio, Italy
700    1_
$a Alessi, Sarah $u Division of Radiology, Istituto Europeo di Oncologia, Milan, Italy
700    1_
$a Pricolo, Paola $u Division of Radiology, Istituto Europeo di Oncologia, Milan, Italy
700    1_
$a Vigorito, Raffaella $u Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
700    1_
$a Calareso, Giuseppina $u Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
700    1_
$a Kocian, Roman $u Gynecologic Oncology Centre, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Slama, Jiri $u Gynecologic Oncology Centre, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Fagotti, Anna $u Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Lazio, Italy
700    1_
$a Urbinati, Ailyn Mariela Vidal $u Preventive Gynecology Unit, Division of Gynecology, European Institute of Oncology, Milan, Italy
700    1_
$a Signorelli, Mauro $u Department of Gynecologic Oncology, Foundation IRCCS National Cancer Institute, Milan, Italy
700    1_
$a Bertolina, Francesca $u Department of Gynecologic Oncology, Foundation IRCCS National Cancer Institute, Milan, Italy
700    1_
$a Cibula, David $u Gynecologic Oncology Centre, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Fischerova, Daniela $u Gynecologic Oncology Centre, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic daniela.fischerova@vfn.cz $1 https://orcid.org/0000000272243218 $7 xx0074804
773    0_
$w MED00009896 $t International journal of gynecological cancer $x 1525-1438 $g Roč. 34, č. 6 (2024), s. 871-878
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38531539 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134010 $b ABA008
999    __
$a ok $b bmc $g 2143409 $s 1225452
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 34 $c 6 $d 871-878 $e 20240603 $i 1525-1438 $m International journal of gynecological cancer $n Int J Gynecol Cancer $x MED00009896
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...